International Biotechnology Trust’s Xenon Pharmaceuticals XENE Stock Holding History

International Biotechnology Trust’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.12M	Buy	91,500 +66,000	+259%	+$2.47M	1.05%	31
2023 Q2	$982K	Hold	25,500	–	–	0.3%	45
2023 Q1	$912K	Hold	25,500	–	–	0.25%	51
2022 Q4	$1M	Hold	25,500	–	–	0.31%	50
2022 Q3	$918K	Buy	25,500 +24,726	+3,195%	+$889K	0.29%	53
2022 Q2	$25.5K	Sell	774 -24,726	-97%	-$748K	0.27%	59
2022 Q1	$3.2M	Hold	25,500	–	–	0.72%	34
2021 Q4	$797K	Hold	25,500	–	–	0.18%	62
2021 Q3	$388K	Hold	25,500	–	–	0.09%	62
2021 Q2	$474K	Buy	+25,500	New	+$470K	0.13%	62

Other funds holding XENE

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

International Biotechnology Trust's XENE Position: Q3 2023 in Review

International Biotechnology Trust increased its Xenon Pharmaceuticals (XENE) stake by 259% in Q3 2023, buying an estimated $2.47M and bringing the position to 91,500 shares worth $3.12M. The position accounts for 1.05% of the portfolio, ranked #31.

International Biotechnology Trust first reported a position in XENE in Q2 2021 and has held it in 10 quarters since. The position peaked at $3.2M in Q1 2022. 180 funds tracked by Wall St. Rank hold XENE as of Q3 2023.

International Biotechnology Trust held 91,500 shares of Xenon Pharmaceuticals worth $3.12M as of Q3 2023.
International Biotechnology Trust bought 66,000 Xenon Pharmaceuticals shares in Q3 2023, an estimated $2.47M.
Xenon Pharmaceuticals made up 1.05% of International Biotechnology Trust's portfolio in Q3 2023, its #31 holding.
International Biotechnology Trust first reported a position in Xenon Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
International Biotechnology Trust's Xenon Pharmaceuticals position peaked at $3.2M in Q1 2022.
180 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.